Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Find ways to stay ahead in budgeting with routine reviews, alerts, and smart adjustments that protect your financial path.
21,896 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...
A federal judge denied the FTC’s request for a partial summary judgment in the Zillow-Redfin rental listings antitrus...
Robinhood Chain has sparked a rapid surge in crypto conversations after its Layer 2 launch, with tokenized assets and...
Investors rewarded Meta Platforms after news suggesting a sharper AI-driven monetization strategy and resilient ad de...
Fans chase closeness to celebrities through small, affordable items that feel like a real link to the stars. This tre...
Analogs chip stocks rebound as demand stabilizes and inventories tighten, signaling a cycle turn for the semiconducto...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
A hypothetical $10,000 investment in Lockheed Martin at the Iran conflict’s start would be down about 22% by late Apr...
A $250,000 SPIA promises $1,600 a month for life, but it comes with lock-in, fees, and a trade-off between predictabl...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...